chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling, Vaccination site warmth
Clinical narrative: Injection site hot; Injection site became  itchy; Injection site became red; Injection site became swollen; Felt very low in energy; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (Felt very low in energy), VACCINATION SITE WARMTH (Injection site hot), VACCINATION SITE PRURITUS (Injection site became  itchy), VACCINATION SITE ERYTHEMA (Injection site became red) and VACCINATION SITE SWELLING (Injection site became swollen) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Apr-2021, the patient experienced ASTHENIA (Felt very low in energy). On 20-Apr-2021, the patient experienced VACCINATION SITE ERYTHEMA (Injection site became red) and VACCINATION SITE SWELLING (Injection site became swollen). On an unknown date, the patient experienced VACCINATION SITE WARMTH (Injection site hot) and VACCINATION SITE PRURITUS (Injection site became  itchy). On 14-Apr-2021, ASTHENIA (Felt very low in energy) had resolved. At the time of the report, VACCINATION SITE WARMTH (Injection site hot), VACCINATION SITE PRURITUS (Injection site became  itchy), VACCINATION SITE ERYTHEMA (Injection site became red) and VACCINATION SITE SWELLING (Injection site became swollen) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  Treatment information was not provided by the reporter.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Received first dose back in January/received second dose today 22Apr2021; This spontaneous case was reported by a health care professional and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received first dose back in January/received second dose today 22Apr2021) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 038A21A and 011L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 22-Apr-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received first dose back in January/received second dose today 22Apr2021). On 22-Apr-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received first dose back in January/received second dose today 22Apr2021) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications details were not reported by the reporter. Treatment details not reported by the reporter.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Pyrexia, Vaccination site pain, Vaccination site swelling
Clinical narrative: sore arm; swollen arm; fever 100; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (sore arm), VACCINATION SITE SWELLING (swollen arm) and PYREXIA (fever 100) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 037B21A and 047A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 20-Apr-2021, the patient experienced VACCINATION SITE PAIN (sore arm), VACCINATION SITE SWELLING (swollen arm) and PYREXIA (fever 100). On 21-Apr-2021, PYREXIA (fever 100) had resolved. At the time of the report, VACCINATION SITE PAIN (sore arm) and VACCINATION SITE SWELLING (swollen arm) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 20-Apr-2021, Body temperature: 100 (High) 100.         No relevant concomitant product were reported  No treatment information was provided.  The patient received both scheduled doses of mRNA-1273 prior to the events; therefore, action taken with the drug in response to the events is not applicable.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Asthenia, Body temperature, Chills, Fatigue
Clinical narrative: joint ache; Headache; Feels very weak; fever of 100.6 degrees F; Chills; feels very tired; arm at site of vaccination is sore; Arm at injection site tender; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (Feels very weak), PYREXIA (fever of 100.6 degrees F), CHILLS (Chills), FATIGUE (feels very tired) and VACCINATION SITE PAIN (arm at site of vaccination is sore) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19. Concurrent medical conditions included Lung disorder NOS and Allergy. Concomitant products included OXYMETAZOLINE HYDROCHLORIDE (CLARITIN ALLERGIC) for Allergy, LISINOPRIL, MULTIVITAMINS [VITAMINS NOS], VITAMIN D NOS, BIOTIN, MAGNESIUM and POTASSIUM for an unknown indication.    On 19-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Apr-2021, the patient experienced ASTHENIA (Feels very weak), PYREXIA (fever of 100.6 degrees F), CHILLS (Chills), FATIGUE (feels very tired), VACCINATION SITE PAIN (arm at site of vaccination is sore) and INJECTION SITE PAIN (Arm at injection site tender). On an unknown date, the patient experienced ARTHRALGIA (joint ache) and HEADACHE (Headache). The patient was treated with PARACETAMOL at a dose of 1 dosage form; BUDESONIDE;FORMOTEROL at a dose of 1 dosage form; UMECLIDINIUM BROMIDE at a dose of 1 dosage form; ALBUTEROL SULFATE at a dose of 1 dosage form and IPRATROPIUM at a dose of 1 dosage form. At the time of the report, ASTHENIA (Feels very weak), PYREXIA (fever of 100.6 degrees F), CHILLS (Chills), FATIGUE (feels very tired), VACCINATION SITE PAIN (arm at site of vaccination is sore) and INJECTION SITE PAIN (Arm at injection site tender) had not resolved and ARTHRALGIA (joint ache) and HEADACHE (Headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 20-Apr-2021, Body temperature: 100.6 f (High) 100.6 F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications also  included, water pills, thyroid medication and cholesterol medication.  Treatment medication also included nebulizer and CPAP machine.   This case was linked to MOD21-080713 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 22-Apr-2021: Follow up information was and patient's contact details updated.Treatment medications updated. On 22-Apr-2021: Live follow-up received and appended on 23-Apr-2021.New events headache and joint pain updated.; Sender's Comments:  MOD21-080713:
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Injection site pain, Pyrexia, Vaccination site pain
Clinical narrative: joint ache; Headache; Feels very weak; fever of 100.6 degrees F; Chills; feels very tired; arm at site of vaccination is sore; Arm at injection site tender; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (Feels very weak), PYREXIA (fever of 100.6 degrees F), CHILLS (Chills), FATIGUE (feels very tired) and VACCINATION SITE PAIN (arm at site of vaccination is sore) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19. Concurrent medical conditions included Lung disorder NOS and Allergy. Concomitant products included OXYMETAZOLINE HYDROCHLORIDE (CLARITIN ALLERGIC) for Allergy, LISINOPRIL, MULTIVITAMINS [VITAMINS NOS], VITAMIN D NOS, BIOTIN, MAGNESIUM and POTASSIUM for an unknown indication.    On 19-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Apr-2021, the patient experienced ASTHENIA (Feels very weak), PYREXIA (fever of 100.6 degrees F), CHILLS (Chills), FATIGUE (feels very tired), VACCINATION SITE PAIN (arm at site of vaccination is sore) and INJECTION SITE PAIN (Arm at injection site tender). On an unknown date, the patient experienced ARTHRALGIA (joint ache) and HEADACHE (Headache). The patient was treated with PARACETAMOL at a dose of 1 dosage form; BUDESONIDE;FORMOTEROL at a dose of 1 dosage form; UMECLIDINIUM BROMIDE at a dose of 1 dosage form; ALBUTEROL SULFATE at a dose of 1 dosage form and IPRATROPIUM at a dose of 1 dosage form. At the time of the report, ASTHENIA (Feels very weak), PYREXIA (fever of 100.6 degrees F), CHILLS (Chills), FATIGUE (feels very tired), VACCINATION SITE PAIN (arm at site of vaccination is sore) and INJECTION SITE PAIN (Arm at injection site tender) had not resolved and ARTHRALGIA (joint ache) and HEADACHE (Headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 20-Apr-2021, Body temperature: 100.6 f (High) 100.6 F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications also  included, water pills, thyroid medication and cholesterol medication.  Treatment medication also included nebulizer and CPAP machine.   This case was linked to MOD21-080713 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 22-Apr-2021: Follow up information was and patient's contact details updated.Treatment medications updated. On 22-Apr-2021: Live follow-up received and appended on 23-Apr-2021.New events headache and joint pain updated.; Sender's Comments:  MOD21-080713:
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Insomnia, Lymphadenopathy, Vaccination site reaction, Viral infection
Clinical narrative: Lack of sleep; Moderna arm; COVID symptoms; Fatigue; Lymph nodes swelling; This spontaneous case was reported by a nurse and describes the occurrence of INSOMNIA (Lack of sleep), VACCINATION SITE REACTION (Moderna arm), VIRAL INFECTION (COVID symptoms), FATIGUE (Fatigue) and LYMPHADENOPATHY (Lymph nodes swelling) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025620A) for COVID-19 vaccination.     No Medical History information was reported.   On 01-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 2 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INSOMNIA (Lack of sleep), VACCINATION SITE REACTION (Moderna arm), VIRAL INFECTION (COVID symptoms), FATIGUE (Fatigue) and LYMPHADENOPATHY (Lymph nodes swelling). At the time of the report, INSOMNIA (Lack of sleep), VACCINATION SITE REACTION (Moderna arm), VIRAL INFECTION (COVID symptoms), FATIGUE (Fatigue) and LYMPHADENOPATHY (Lymph nodes swelling) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported. Treatment information was not provided by the reporter.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Swelling, Urticaria, Vaccination site pain
Clinical narrative: bumps; hives; Pain at injection site; itchy hips; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING (bumps), URTICARIA (hives), PRURITUS (itchy hips) and VACCINATION SITE PAIN (Pain at injection site) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 07-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Apr-2021, the patient experienced PRURITUS (itchy hips). On an unknown date, the patient experienced SWELLING (bumps), URTICARIA (hives) and VACCINATION SITE PAIN (Pain at injection site). At the time of the report, SWELLING (bumps), URTICARIA (hives), PRURITUS (itchy hips) and VACCINATION SITE PAIN (Pain at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment includes Benadryl.   This case was linked to US-MODERNATX, INC.-MOD-2021-077991 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-077991:crosslinked case.
Age: 48.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Hyperhidrosis, Parosmia, Taste disorder
Clinical narrative: When he sweats, he smells "burnt motor oil"; bad taste in mouth; Everything smells like burnt motor oi; This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (When he sweats, he smells "burnt motor oil"), TASTE DISORDER (bad taste in mouth) and PAROSMIA (Everything smells like burnt motor oi) in a 48-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes, Blood pressure and High cholesterol.    On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Mar-2021, the patient experienced HYPERHIDROSIS (When he sweats, he smells "burnt motor oil"), TASTE DISORDER (bad taste in mouth) and PAROSMIA (Everything smells like burnt motor oi). At the time of the report, HYPERHIDROSIS (When he sweats, he smells "burnt motor oil"), TASTE DISORDER (bad taste in mouth) and PAROSMIA (Everything smells like burnt motor oi) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In November 2020, COVID-19: positive (Positive) positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication include blood pressure pills, cholesterol pills, and insulin.   This case was linked to US-MODERNATX, INC.-MOD-2021-085861 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-085861:
Age: 41.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Device connection issue, Pyrexia, Underdose
Clinical narrative: syringe froze and got stuck so he had to pull it out before the full dose could be administered; received  0.2ml of the dose; fever; chills; This spontaneous case was reported by a physician and describes the occurrence of DEVICE CONNECTION ISSUE (syringe froze and got stuck so he had to pull it out before the full dose could be administered), UNDERDOSE (received  0.2ml of the dose), PYREXIA (fever) and CHILLS (chills) in a 41-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Apr-2021, the patient experienced DEVICE CONNECTION ISSUE (syringe froze and got stuck so he had to pull it out before the full dose could be administered), UNDERDOSE (received  0.2ml of the dose), PYREXIA (fever) and CHILLS (chills). At the time of the report, DEVICE CONNECTION ISSUE (syringe froze and got stuck so he had to pull it out before the full dose could be administered), UNDERDOSE (received  0.2ml of the dose), PYREXIA (fever) and CHILLS (chills) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported. No treatment medication was reported.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Confusional state, Dysgeusia, Fatigue, Headache
Clinical narrative: Confusion; Coffee taste in the morning today does not feel right; I feel I have headaches; Fever; Nausea; Fatigue; Major (mid night chills) chills; Muscle aces; This spontaneous case was reported by a consumer and describes the occurrence of CONFUSIONAL STATE (Confusion), DYSGEUSIA (Coffee taste in the morning today does not feel right), HEADACHE (I feel I have headaches), PYREXIA (Fever) and NAUSEA (Nausea) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 042821A and 003AZIA) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included TRAZODONE, VALPROATE SEMISODIUM (DEPAKOTE) and BUPROPION HYDROCHLORIDE (WELLBUTRIN) for Depression, IBUPROFEN for an unknown indication.   On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 22-Apr-2021, the patient experienced CONFUSIONAL STATE (Confusion), DYSGEUSIA (Coffee taste in the morning today does not feel right), HEADACHE (I feel I have headaches), PYREXIA (Fever), NAUSEA (Nausea), FATIGUE (Fatigue), CHILLS (Major (mid night chills) chills) and MYALGIA (Muscle aces). At the time of the report, CONFUSIONAL STATE (Confusion), DYSGEUSIA (Coffee taste in the morning today does not feel right), HEADACHE (I feel I have headaches), PYREXIA (Fever), NAUSEA (Nausea), FATIGUE (Fatigue), CHILLS (Major (mid night chills) chills) and MYALGIA (Muscle aces) had not resolved.            The patient post receiving their second dose of vaccine felt like having headaches, fever, nausea, confusion, fatigue, major mid night chills, muscle aches and coffee taste in the morning next day. The patient felt a little bit better but reported that the symptoms were still ongoing.   The patient did not take any treatments to help with the symptoms.   Most recent FOLLOW-UP information incorporated above includes: On 26-May-2021: Follow-up information received on 26-May-2021 contains non-significant information which included reporter's Email address.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Nausea, Pyrexia
Clinical narrative: Confusion; Coffee taste in the morning today does not feel right; I feel I have headaches; Fever; Nausea; Fatigue; Major (mid night chills) chills; Muscle aces; This spontaneous case was reported by a consumer and describes the occurrence of CONFUSIONAL STATE (Confusion), DYSGEUSIA (Coffee taste in the morning today does not feel right), HEADACHE (I feel I have headaches), PYREXIA (Fever) and NAUSEA (Nausea) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 042821A and 003AZIA) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included TRAZODONE, VALPROATE SEMISODIUM (DEPAKOTE) and BUPROPION HYDROCHLORIDE (WELLBUTRIN) for Depression, IBUPROFEN for an unknown indication.   On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 22-Apr-2021, the patient experienced CONFUSIONAL STATE (Confusion), DYSGEUSIA (Coffee taste in the morning today does not feel right), HEADACHE (I feel I have headaches), PYREXIA (Fever), NAUSEA (Nausea), FATIGUE (Fatigue), CHILLS (Major (mid night chills) chills) and MYALGIA (Muscle aces). At the time of the report, CONFUSIONAL STATE (Confusion), DYSGEUSIA (Coffee taste in the morning today does not feel right), HEADACHE (I feel I have headaches), PYREXIA (Fever), NAUSEA (Nausea), FATIGUE (Fatigue), CHILLS (Major (mid night chills) chills) and MYALGIA (Muscle aces) had not resolved.            The patient post receiving their second dose of vaccine felt like having headaches, fever, nausea, confusion, fatigue, major mid night chills, muscle aches and coffee taste in the morning next day. The patient felt a little bit better but reported that the symptoms were still ongoing.   The patient did not take any treatments to help with the symptoms.   Most recent FOLLOW-UP information incorporated above includes: On 26-May-2021: Follow-up information received on 26-May-2021 contains non-significant information which included reporter's Email address.
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Wife had fever after vaccine; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Wife had fever after vaccine) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 22-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PYREXIA (Wife had fever after vaccine). At the time of the report, PYREXIA (Wife had fever after vaccine) outcome was unknown. Not Provided          Concomitant medication was not provided. Treatment information was not provided.  The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was not applicable.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Influenza like illness, Myalgia, Pain, Palpitations
Clinical narrative: Pain; flu-like symptoms; palpitation; arm muscle was really sore; This spontaneous case was reported by a nurse and describes the occurrence of PAIN (Pain), INFLUENZA LIKE ILLNESS (flu-like symptoms), PALPITATIONS (palpitation) and MYALGIA (arm muscle was really sore) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 0021321A and 040821A) for COVID-19 vaccination.     No medical history was reported.  Concomitant products included VALSARTAN, VITAMIN C [ASCORBIC ACID], VITAMIN D [VITAMIN D NOS] and MULTIVITAMIN [VITAMINS NOS] for an unknown indication.   On 14-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Apr-2021, the patient experienced PAIN (Pain), INFLUENZA LIKE ILLNESS (flu-like symptoms), PALPITATIONS (palpitation) and MYALGIA (arm muscle was really sore). At the time of the report, PAIN (Pain), INFLUENZA LIKE ILLNESS (flu-like symptoms), PALPITATIONS (palpitation) and MYALGIA (arm muscle was really sore) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment medications include Tylenol and Advil.   This case was linked to (E2B Linked Report).; Sender's Comments:
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Alopecia
Clinical narrative: massive hair loss; This spontaneous case was reported by a consumer and describes the occurrence of ALOPECIA (massive hair loss) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-Mar-2021, the patient experienced ALOPECIA (massive hair loss). The patient was treated with ZINC for Adverse event, at an unspecified dose and frequency and BIOTIN for Adverse event, at an unspecified dose and frequency. At the time of the report, ALOPECIA (massive hair loss) outcome was unknown. Not Provided          This case was linked to MOD21-080638 (E2B Linked Report).; Sender's Comments:  MOD21-080638:
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Feeling abnormal, Feeling cold, Hyperhidrosis, Musculoskeletal stiffness
Clinical narrative: arm was stif; lightheaded; not feeling like herself; started freezing; Really really cold; bed was soaked and wet, mattress was wet, pillows, covers, everything; just not feeling good and shaking; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULOSKELETAL STIFFNESS (arm was stif), DIZZINESS (lightheaded), FEELING ABNORMAL (not feeling like herself), FEELING COLD (started freezing) and FEELING COLD (Really really cold) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043B71A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event. Concomitant products included HYDROCHLOROTHIAZIDE for an unknown indication.    On 20-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced MUSCULOSKELETAL STIFFNESS (arm was stif), DIZZINESS (lightheaded), FEELING ABNORMAL (not feeling like herself), FEELING COLD (started freezing), FEELING COLD (Really really cold), HYPERHIDROSIS (bed was soaked and wet, mattress was wet, pillows, covers, everything) and TREMOR (just not feeling good and shaking). At the time of the report, MUSCULOSKELETAL STIFFNESS (arm was stif), DIZZINESS (lightheaded), FEELING ABNORMAL (not feeling like herself), FEELING COLD (started freezing), FEELING COLD (Really really cold), HYPERHIDROSIS (bed was soaked and wet, mattress was wet, pillows, covers, everything) and TREMOR (just not feeling good and shaking) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Upon internal review on 04-Aug-2021, the age was corrected to 60 years.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Tremor
Clinical narrative: arm was stif; lightheaded; not feeling like herself; started freezing; Really really cold; bed was soaked and wet, mattress was wet, pillows, covers, everything; just not feeling good and shaking; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULOSKELETAL STIFFNESS (arm was stif), DIZZINESS (lightheaded), FEELING ABNORMAL (not feeling like herself), FEELING COLD (started freezing) and FEELING COLD (Really really cold) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043B71A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event. Concomitant products included HYDROCHLOROTHIAZIDE for an unknown indication.    On 20-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced MUSCULOSKELETAL STIFFNESS (arm was stif), DIZZINESS (lightheaded), FEELING ABNORMAL (not feeling like herself), FEELING COLD (started freezing), FEELING COLD (Really really cold), HYPERHIDROSIS (bed was soaked and wet, mattress was wet, pillows, covers, everything) and TREMOR (just not feeling good and shaking). At the time of the report, MUSCULOSKELETAL STIFFNESS (arm was stif), DIZZINESS (lightheaded), FEELING ABNORMAL (not feeling like herself), FEELING COLD (started freezing), FEELING COLD (Really really cold), HYPERHIDROSIS (bed was soaked and wet, mattress was wet, pillows, covers, everything) and TREMOR (just not feeling good and shaking) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Upon internal review on 04-Aug-2021, the age was corrected to 60 years.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Allergy to vaccine, Pruritus, Urticaria
Clinical narrative: allergy; itching all over her body; welts; This spontaneous case was reported by a consumer and describes the occurrence of ALLERGY TO VACCINE (allergy), PRURITUS (itching all over her body) and URTICARIA (welts) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (Batch no. 037B21A/10/1/20) for COVID-19 vaccination.     Concurrent medical conditions included Allergy to antibiotic (Quinolone). Concomitant products included PANCREATIN (CREON), APIXABAN (ELIQUIS), FUROSEMIDE, POTASSIUM, SPIRONOLACTONE and APIXABAN for an unknown indication.    On 16-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Apr-2021, the patient experienced ALLERGY TO VACCINE (allergy), PRURITUS (itching all over her body) and URTICARIA (welts). The patient was treated with LORATADINE (CLARITIN [LORATADINE]) at an unspecified dose and frequency. At the time of the report, ALLERGY TO VACCINE (allergy), PRURITUS (itching all over her body) and URTICARIA (welts) outcome was unknown. Not Provided          The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was not applicable.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Disorientation, Dizziness, Dysgeusia, Fatigue, Influenza like illness
Clinical narrative: flu-like symptoms; he is disoriented; feels dizzy; taste buds really tasted funny; fever; body aches; Tired; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (flu-like symptoms), DISORIENTATION (he is disoriented), DIZZINESS (feels dizzy), DYSGEUSIA (taste buds really tasted funny) and PYREXIA (fever) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Immune system disorder (pre-existing compromised immune system).    On 21-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (flu-like symptoms), DISORIENTATION (he is disoriented), DIZZINESS (feels dizzy), DYSGEUSIA (taste buds really tasted funny), PYREXIA (fever), MYALGIA (body aches) and FATIGUE (Tired). At the time of the report, INFLUENZA LIKE ILLNESS (flu-like symptoms), DISORIENTATION (he is disoriented), DIZZINESS (feels dizzy), DYSGEUSIA (taste buds really tasted funny), PYREXIA (fever), MYALGIA (body aches) and FATIGUE (Tired) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       This case was linked to US-MODERNATX, INC.-MOD-2021-086105 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-086105:crosslinked
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Myalgia, Pyrexia
Clinical narrative: flu-like symptoms; he is disoriented; feels dizzy; taste buds really tasted funny; fever; body aches; Tired; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (flu-like symptoms), DISORIENTATION (he is disoriented), DIZZINESS (feels dizzy), DYSGEUSIA (taste buds really tasted funny) and PYREXIA (fever) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Immune system disorder (pre-existing compromised immune system).    On 21-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (flu-like symptoms), DISORIENTATION (he is disoriented), DIZZINESS (feels dizzy), DYSGEUSIA (taste buds really tasted funny), PYREXIA (fever), MYALGIA (body aches) and FATIGUE (Tired). At the time of the report, INFLUENZA LIKE ILLNESS (flu-like symptoms), DISORIENTATION (he is disoriented), DIZZINESS (feels dizzy), DYSGEUSIA (taste buds really tasted funny), PYREXIA (fever), MYALGIA (body aches) and FATIGUE (Tired) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       This case was linked to US-MODERNATX, INC.-MOD-2021-086105 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-086105:crosslinked
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: pain in arm of the injection; This spontaneous case was reported by a pharmacist and describes the occurrence of PAIN IN EXTREMITY (pain in arm of the injection) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003B21A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (pain in arm of the injection). At the time of the report, PAIN IN EXTREMITY (pain in arm of the injection) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment medications were reported.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Influenza like illness, Myalgia, Pain in extremity, Palpitations
Clinical narrative: Flu-like symptoms; Palpitations; arm sore; Arm muscle was really sore; This spontaneous case was reported by a nurse and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu-like symptoms), PALPITATIONS (Palpitations), PAIN IN EXTREMITY (arm sore) and MYALGIA (Arm muscle was really sore) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 0021321A and 040821A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included VALSARTAN, COLECALCIFEROL (VITAMIN D [COLECALCIFEROL]), VITAMIN C [ASCORBIC ACID] and MULTIVITAMIN [ASCORBIC ACID;CALCIUM PANTOTHENATE;COLECALCIFEROL;CYANOCOBALAMIN;NICOTINAMIDE;PYRIDOXINE HYDROCHLORIDE;RETINOL;RIBOFLAVIN;THIAMINE HYDROCHLORIDE] for an unknown indication.   On 14-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Apr-2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu-like symptoms), PALPITATIONS (Palpitations), PAIN IN EXTREMITY (arm sore) and MYALGIA (Arm muscle was really sore). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency. At the time of the report, INFLUENZA LIKE ILLNESS (Flu-like symptoms), PALPITATIONS (Palpitations), PAIN IN EXTREMITY (arm sore) and MYALGIA (Arm muscle was really sore) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   This case was linked to US-MODERNATX, INC.-MOD-2021-085849 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-085849:
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, Diarrhoea, Emotional distress, Fatigue
Clinical narrative: normal congestion; diarrhea; body aches; extreme emotional distress; lost sense of smell and taste; still little bit of fatigue; lost sense of smell and taste; serious outbreak of psoriasis; tested positive for Covid-19; This spontaneous case was reported by a consumer and describes the occurrence of AGEUSIA (lost sense of smell and taste), PSORIASIS (serious outbreak of psoriasis), SARS-COV-2 TEST POSITIVE (tested positive for Covid-19), NASAL CONGESTION (normal congestion) and DIARRHOEA (diarrhea) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 29-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Apr-2021, the patient experienced PSORIASIS (serious outbreak of psoriasis) and SARS-COV-2 TEST POSITIVE (tested positive for Covid-19). On an unknown date, the patient experienced AGEUSIA (lost sense of smell and taste), NASAL CONGESTION (normal congestion), DIARRHOEA (diarrhea), PAIN (body aches), EMOTIONAL DISTRESS (extreme emotional distress), ANOSMIA (lost sense of smell and taste) and FATIGUE (still little bit of fatigue). The patient was treated with VITAMIN D NOS at an unspecified dose and frequency. At the time of the report, AGEUSIA (lost sense of smell and taste), PSORIASIS (serious outbreak of psoriasis), SARS-COV-2 TEST POSITIVE (tested positive for Covid-19), NASAL CONGESTION (normal congestion), DIARRHOEA (diarrhea), PAIN (body aches), EMOTIONAL DISTRESS (extreme emotional distress), ANOSMIA (lost sense of smell and taste) and FATIGUE (still little bit of fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medications also included antihistamine and steroids cream. No concomitant medications were reported.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Nasal congestion, Pain, Psoriasis, SARS-CoV-2 test positive
Clinical narrative: normal congestion; diarrhea; body aches; extreme emotional distress; lost sense of smell and taste; still little bit of fatigue; lost sense of smell and taste; serious outbreak of psoriasis; tested positive for Covid-19; This spontaneous case was reported by a consumer and describes the occurrence of AGEUSIA (lost sense of smell and taste), PSORIASIS (serious outbreak of psoriasis), SARS-COV-2 TEST POSITIVE (tested positive for Covid-19), NASAL CONGESTION (normal congestion) and DIARRHOEA (diarrhea) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 29-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Apr-2021, the patient experienced PSORIASIS (serious outbreak of psoriasis) and SARS-COV-2 TEST POSITIVE (tested positive for Covid-19). On an unknown date, the patient experienced AGEUSIA (lost sense of smell and taste), NASAL CONGESTION (normal congestion), DIARRHOEA (diarrhea), PAIN (body aches), EMOTIONAL DISTRESS (extreme emotional distress), ANOSMIA (lost sense of smell and taste) and FATIGUE (still little bit of fatigue). The patient was treated with VITAMIN D NOS at an unspecified dose and frequency. At the time of the report, AGEUSIA (lost sense of smell and taste), PSORIASIS (serious outbreak of psoriasis), SARS-COV-2 TEST POSITIVE (tested positive for Covid-19), NASAL CONGESTION (normal congestion), DIARRHOEA (diarrhea), PAIN (body aches), EMOTIONAL DISTRESS (extreme emotional distress), ANOSMIA (lost sense of smell and taste) and FATIGUE (still little bit of fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medications also included antihistamine and steroids cream. No concomitant medications were reported.
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Having pain in right arm at injection shot; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Having pain in right arm at injection shot) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040AZIA) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Mar-2021, the patient experienced VACCINATION SITE PAIN (Having pain in right arm at injection shot). At the time of the report, VACCINATION SITE PAIN (Having pain in right arm at injection shot) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.  Treatment information was not provided.
Age: 17.0
Sex: U
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: my associate administer a vaccine who is not 18 until July; This spontaneous case was reported by a physician and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (my associate administer a vaccine who is not 18 until July) in a 17-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 22-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Apr-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (my associate administer a vaccine who is not 18 until July). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (my associate administer a vaccine who is not 18 until July) outcome was unknown. Not Provided    Concomitant and treatment details were not provided.  The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Myalgia, Pyrexia
Clinical narrative: Headache; Muscle Ache; Fever; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache), MYALGIA (Muscle Ache) and PYREXIA (Fever) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 25-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Feb-2021, the patient experienced HEADACHE (Headache), MYALGIA (Muscle Ache) and PYREXIA (Fever). On 25-Feb-2021, HEADACHE (Headache) had resolved. On 26-Feb-2021, MYALGIA (Muscle Ache) and PYREXIA (Fever) had resolved. Not Provided          No Relevant concomitant medications was reported. Treatment information was not provided.   This case was linked to MOD-2021-025734 (Patient Link).
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Limb discomfort, Pain in extremity
Clinical narrative: Soreness in injection ar; Heaviness in injection ar; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Soreness in injection ar) and LIMB DISCOMFORT (Heaviness in injection ar) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. On 20-Mar-2021, the patient experienced PAIN IN EXTREMITY (Soreness in injection ar) and LIMB DISCOMFORT (Heaviness in injection ar). At the time of the report, PAIN IN EXTREMITY (Soreness in injection ar) and LIMB DISCOMFORT (Heaviness in injection ar) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications provided. No treatment information provided.   This case was linked to MOD-2021-085909.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Pyrexia
Clinical narrative: Up and down fever of 101.9; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Up and down fever of 101.9) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 021B21A and 046821A) for COVID-19 vaccination.     No Medical History information was reported.   On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 21-Apr-2021, the patient experienced PYREXIA (Up and down fever of 101.9). At the time of the report, PYREXIA (Up and down fever of 101.9) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 21-Apr-2021, Body temperature: 101.9 (High) fever of 100.4, then went down, and is now 101.9.         No concomitant medication was reported by the reporter. No treatment was reported by the reporter.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Diarrhoea, Feeling cold, Nausea, Pyrexia
Clinical narrative: diarrhea; trembling; very cold; arm is very tender; shivering; nausea; vomiting around 12pm; fever range from 101.5 to 102; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarrhea), TREMOR (trembling), FEELING COLD (very cold), TENDERNESS (arm is very tender) and CHILLS (shivering) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 21-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Apr-2021, the patient experienced DIARRHOEA (diarrhea), TREMOR (trembling), FEELING COLD (very cold), TENDERNESS (arm is very tender), CHILLS (shivering), NAUSEA (nausea), VOMITING (vomiting around 12pm) and PYREXIA (fever range from 101.5 to 102). At the time of the report, DIARRHOEA (diarrhea), TREMOR (trembling), FEELING COLD (very cold), TENDERNESS (arm is very tender), CHILLS (shivering), NAUSEA (nausea), VOMITING (vomiting around 12pm) and PYREXIA (fever range from 101.5 to 102) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       no concomitant medication provided by reporter no treatment information provided by reporter